{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T22:51:03Z","timestamp":1740178263167,"version":"3.37.3"},"reference-count":16,"publisher":"American Society of Hematology","issue":"18","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,9,26]]},"DOI":"10.1182\/bloodadvances.2023010223","type":"journal-article","created":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T15:14:06Z","timestamp":1688138046000},"page":"5320-5324","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3123-6844","authenticated-orcid":false,"given":"Rahul","family":"Lakhotia","sequence":"first","affiliation":[{"name":"1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kieron","family":"Dunleavy","sequence":"additional","affiliation":[{"name":"2Department of Hematology-Oncology, Georgetown University, Washington, DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8467-9257","authenticated-orcid":false,"given":"Jeremy S.","family":"Abramson","sequence":"additional","affiliation":[{"name":"3Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5084-0698","authenticated-orcid":false,"given":"Brian K.","family":"Link","sequence":"additional","affiliation":[{"name":"4Department of Medicine, University of Iowa, Iowa City, IA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bayard L.","family":"Powell","sequence":"additional","affiliation":[{"name":"5Department of Internal Medicine-Section on Hematology and Oncology, Wake Forest School of Medicine, Winston-Salem, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9661-4570","authenticated-orcid":false,"given":"Christopher","family":"Melani","sequence":"additional","affiliation":[{"name":"1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea N.","family":"Lucas","sequence":"additional","affiliation":[{"name":"1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seth M.","family":"Steinberg","sequence":"additional","affiliation":[{"name":"6Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan W.","family":"Friedberg","sequence":"additional","affiliation":[{"name":"7Wilmot Cancer Institute, University of Rochester, Rochester, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0459-6609","authenticated-orcid":false,"given":"Brad S.","family":"Kahl","sequence":"additional","affiliation":[{"name":"8Lymphoma Program, Washington University School of Medicine Siteman Cancer Center, St. Louis, MO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4091-1699","authenticated-orcid":false,"given":"Richard F.","family":"Little","sequence":"additional","affiliation":[{"name":"9HIV\/AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy L.","family":"Bartlett","sequence":"additional","affiliation":[{"name":"8Lymphoma Program, Washington University School of Medicine Siteman Cancer Center, St. Louis, MO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariela","family":"Noy","sequence":"additional","affiliation":[{"name":"10Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wyndham H.","family":"Wilson","sequence":"additional","affiliation":[{"name":"1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0278-2635","authenticated-orcid":false,"given":"Mark","family":"Roschewski","sequence":"additional","affiliation":[{"name":"1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2023,9,14]]},"reference":[{"issue":"12","key":"2023092214050542700_bib1","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJMra2025746","article-title":"Burkitt's lymphoma","volume":"387","author":"Roschewski","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"2023092214050542700_bib2","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1200\/JCO.1996.14.3.925","article-title":"Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen","volume":"14","author":"Magrath","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"2023092214050542700_bib3","first-page":"3294","article-title":"Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90","volume":"94","author":"Reiter","year":"1999","journal-title":"Blood"},{"issue":"23","key":"2023092214050542700_bib4","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa1915315","article-title":"Rituximab for high-risk, mature B-cell non-Hodgkin's lymphoma in children","volume":"382","author":"Minard-Colin","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"2023092214050542700_bib5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/bjh.15520","article-title":"Excellent outcomes in children and adolescents with CNS(+) Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB\/LMB96 and COG ANHL01P1","volume":"185","author":"Frazer","year":"2019","journal-title":"Br J Haematol"},{"issue":"10036","key":"2023092214050542700_bib6","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1016\/S0140-6736(15)01317-3","article-title":"Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial","volume":"387","author":"Ribrag","year":"2016","journal-title":"Lancet"},{"issue":"7","key":"2023092214050542700_bib7","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/cncr.21776","article-title":"Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia","volume":"106","author":"Thomas","year":"2006","journal-title":"Cancer"},{"issue":"5","key":"2023092214050542700_bib8","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/ijc.2910490512","article-title":"P-glycoprotein expression and schedule dependence of adriamycin cytotoxicity in human colon carcinoma cell lines","volume":"49","author":"Lai","year":"1991","journal-title":"Int J Cancer"},{"issue":"8","key":"2023092214050542700_bib9","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1200\/JCO.1993.11.8.1573","article-title":"EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma","volume":"11","author":"Wilson","year":"1993","journal-title":"J\u00a0Clin Oncol"},{"issue":"20","key":"2023092214050542700_bib10","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa1308392","article-title":"Low-intensity therapy in adults with Burkitt's lymphoma","volume":"369","author":"Dunleavy","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"2023092214050542700_bib11","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1200\/JCO.20.00303","article-title":"Multicenter study of risk-adapted therapy with dose-adjusted EPOCH-R in adults with untreated Burkitt lymphoma","volume":"38","author":"Roschewski","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"2023092214050542700_bib12","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood.2022016534","article-title":"Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma","volume":"141","author":"Thomas","year":"2023","journal-title":"Blood"},{"issue":"20","key":"2023092214050542700_bib13","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1002\/cncr.28264","article-title":"Population-based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the Surveillance, Epidemiology, and End Results database","volume":"119","author":"Castillo","year":"2013","journal-title":"Cancer"},{"issue":"6","key":"2023092214050542700_bib14","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1182\/blood.V36.6.718.718","article-title":"Central nervous system involvement in Burkitt's lymphoma","volume":"36","author":"Ziegler","year":"1970","journal-title":"Blood"},{"issue":"3","key":"2023092214050542700_bib15","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1182\/blood.2020006926","article-title":"Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers","volume":"137","author":"Evens","year":"2021","journal-title":"Blood"},{"issue":"10","key":"2023092214050542700_bib16","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1200\/JCO.20.03288","article-title":"Burkitt lymphoma international prognostic index","volume":"39","author":"Olszewski","year":"2021","journal-title":"J\u00a0Clin Oncol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/18\/5320\/2080073\/blooda_adv-2023-010223-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/18\/5320\/2080073\/blooda_adv-2023-010223-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T14:06:19Z","timestamp":1695391579000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/18\/5320\/496610\/Prognostic-factors-for-adult-patients-with-Burkitt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,14]]},"references-count":16,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2023,9,26]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023010223","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"type":"print","value":"2473-9529"},{"type":"electronic","value":"2473-9537"}],"subject":[],"published":{"date-parts":[[2023,9,14]]}}}